Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no more participants are being sought. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:15:57.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page adds a Melanoma topic tag and related topics including MedlinePlus Genetics, and updates the site revision from v3.5.4 to v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-05T11:34:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Melanoma keyword tag and the related topics section including MedlinePlus Genetics have been removed, reducing cross-links to related topics on the study page.
    Difference
    0.2%
    Check dated 2026-05-29T07:38:55.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The revision history now lists Revision: v3.5.4, replacing v3.5.3. This indicates a new logged update to the page in the site’s revision history.
    Difference
    0.1%
    Check dated 2026-05-15T04:50:35.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A Related topics section now appears, listing Melanoma and MedlinePlus Genetics to connect users with health information related to the study's condition.
    Difference
    0.2%
    Check dated 2026-05-08T00:51:41.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page revision changed from v3.5.2 to v3.5.3. This update reflects a backend or formatting adjustment and does not modify the study details presented.
    Difference
    0.1%
    Check dated 2026-04-30T18:42:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.